Navitus to Remove Humira from Formularies June 1

Navitus to Remove Humira® from Formularies Effective June 1

More than ten biosimilars to Humira® were launched in 2023, introducing price competitiveness for one of the most utilized drugs on the market....

Read More
Industry News, Specialty

Humira Biosimilars – Update for October Formularies

Our recent August Pharmacy and Therapeutics (P&T) Committee meeting reviewed the release of various Humira® biosimilars. Staying true to our...

Read More
Industry News, Specialty

Humira Biosimilars – Summer of Blockbuster Releases for Navitus to Review

This summer has seen a continuation of the long-awaited market entry of Humira® (adalimumab) biosimilars. As of July 1, nine additional biosimilars...

Read More
Industry News, Specialty

Humira Biosimilars Enter the Marketplace – Update on Navitus’ Review

The market entry of biosimilars to Humira® (adalimumab) is long-awaited. These products have the potential to improve affordability in the near- and...

Read More
Industry News, Specialty

Five Forecasts and Takeaways for Plan Sponsors in 2023

As we enter 2023, David Fields is sharing his top forecasts and takeaways for plan sponsors and the PBM industry.

Read More
Industry News, Specialty

Building Specialty Pharmacy Success

Sharon Faust, PharmD, Vice President of Specialty Pharmacy for Lumicera shares a few key initiatives that will continue to create an impact for...

Read More
Industry News, Specialty
2022 PBM trends for plan sponsors

2022 Pharmacy Benefit Predictions: What Plan Sponsors Should Watch

Navitus’ CEO, David Fields, shares his insights into the pharmacy benefits industry that will help plan sponsors achieve greater cost savings,...

Read More
Industry News, Specialty

In the Pipeline: Specialty Drugs to Watch in 2022

Specialty medication development has grown rapidly, encompassing up to 80% of new FDA drug approvals in recent years. Read on to learn about the most...

Read More
Industry News, Specialty
specialty drugs

[Webinar] How to Better Manage Specialty Drug Spend for Chronic Conditions

Didn’t have time to attend our recent webinar on managing chronic conditions? Don’t worry – we’ve got you covered with a recap!

Read More
Specialty, Webinars

Seize the Opportunity to Control Your Specialty Drug Spend

Provider-administered specialty drugs covered under the medical benefit can cost far more than their average wholesale price (AWP). As a result...

Read More
Industry News, Specialty

Limited Distribution Drugs: What You May Not Know (rerun)

More than 75% of pharmaceutical manufacturers are choosing to limit the number of pharmacies that can dispense certain specialty medications.1 Find...

Read More
Industry News, Specialty

In the Pipeline: Specialty Drugs to Watch in 2021

Despite the pandemic, manufacturers are continuing to develop new drugs, especially specialty medications. Read on for the most important specialty...

Read More
Industry News, Specialty

Recent Posts